Fresenius Kabi is looking for in-licensing opportunities in infusion therapy and clinical nutrition, e.g. in the area of i.v. drugs, more specifically in the areas of pain management/CNS, anesthesia, anti-infectives, inflammation and oncology. More
Fannin Limited has grown through the licensing and distribution of pharmaceutical products in the UK and Irish markets. We wish to talk to any company that may be thinking of rationalising their product portfolio. More
Helicon has identified Emergency Medicine, General and Cosmetic Surgery and Oncology markets as high potential segments in China and is seeking products with a strategic fit to the existing portfolio. More
Displaying 1..10 of 18 -
per page
Next page
Order by